Dr. Steven Quay presented at the Precision Medicine World Conference (Virtual)

Play Video

On January 26th, 2021 Dr. Steven Quay presented at the PMWC (Virtual). He spoke in the “Development of New SARS CoV 2 Therapeutics”. You can watch his segment above which is the first 21 minutes of the video.

Monica Herrera and George Carlin Yuman from Bio-Rad Laboratories introduce the session on the development of Source Code V2 therapeutics, focusing on COVID-19. Monica Herrera, Director of Molecular Diagnostics, and Dr. George Carlin Yuman, Director of Scientific Affairs, present the agenda, highlighting four topics: prophylaxis, antivirals, plasma therapy, and anti-inflammatories, with various experts in each field. They stress the urgency for more research and development due to the ongoing COVID-19 pandemic’s impact.

They discuss the pathogenesis of the disease, emphasizing the importance of early antiviral therapies and later immune modulators. They mention ongoing clinical trials and introduce speakers who discuss their approaches to therapeutics development, including Dr. Steven Quay and Dr. Ashish Manglik, who present their respective programs on prophylaxis using nasal sprays and nanobodies targeting the spike protein to prevent viral entry. They address questions on the efficacy and availability of their compounds, highlighting the potential of nasal applications for strong prophylaxis.

For more information about PMWC:

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

In a recent conversation on The Vince Coglianese Show, Dr. Steven Quay shares his thoughts on various aspects of the COVID-19 pandemic, shedding light on critical issues ranging from the origins of the virus to the trust deficit in the medical community.

The recent House Committee testimony has stirred up discussions regarding public health, vaccination, and trust in government agencies. Dr. Quay breaks down Dr. Fuaci's testimony with Rich Valdés on this 2 hour podcast.

Dr. Steven Quay is featured on NewsNation to discuss a new medical breakthrough cancer pill which early research suggests it destroys all solid tumors. Dr. Quay says it’s a “highly significant finding”.